Underlying NPAT was $51.8M, with statutory NPAT at $39.4M after a UK/Ireland goodwill impairment. Revenue rose 5% year-over-year, but EBIT and EBITDA declined; FY25 NPAT is expected to increase despite ongoing economic headwinds.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.